These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 15994944)
41. Jab1 interacts with brain-specific kinase 2 (BRSK2) and promotes its degradation in the ubiquitin-proteasome pathway. Zhou J; Wan B; Li R; Gu X; Zhong Z; Wang Y; Yu L Biochem Biophys Res Commun; 2012 Jun; 422(4):647-52. PubMed ID: 22609399 [TBL] [Abstract][Full Text] [Related]
42. JAB1 regulates unphosphorylated STAT3 DNA-binding activity through protein-protein interaction in human colon cancer cells. Nishimoto A; Kugimiya N; Hosoyama T; Enoki T; Li TS; Hamano K Biochem Biophys Res Commun; 2013 Aug; 438(3):513-8. PubMed ID: 23911788 [TBL] [Abstract][Full Text] [Related]
43. Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells. Deol YS; Nasser MW; Yu L; Zou X; Ganju RK J Biol Chem; 2011 Dec; 286(52):44845-54. PubMed ID: 22016394 [TBL] [Abstract][Full Text] [Related]
44. S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling. Liu H; Wang L; Wang X; Cao Z; Yang Q; Zhang K World J Surg Oncol; 2013 Apr; 11():93. PubMed ID: 23618129 [TBL] [Abstract][Full Text] [Related]
45. Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation. Li H; Huang F; Fan L; Jiang Y; Wang X; Li J; Wang Q; Pan H; Sun J; Cao X; Wang X Oncogene; 2014 Sep; 33(37):4589-98. PubMed ID: 24276246 [TBL] [Abstract][Full Text] [Related]
46. PED mediates AKT-dependent chemoresistance in human breast cancer cells. Stassi G; Garofalo M; Zerilli M; Ricci-Vitiani L; Zanca C; Todaro M; Aragona F; Limite G; Petrella G; Condorelli G Cancer Res; 2005 Aug; 65(15):6668-75. PubMed ID: 16061647 [TBL] [Abstract][Full Text] [Related]
47. Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-κB activation and tumor sphere formation. Glinka Y; Mohammed N; Subramaniam V; Jothy S; Prud'homme GJ Biochem Biophys Res Commun; 2012 Sep; 425(4):775-80. PubMed ID: 22885184 [TBL] [Abstract][Full Text] [Related]
48. Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling. Sneh A; Deol YS; Ganju A; Shilo K; Rosol TJ; Nasser MW; Ganju RK Breast Cancer Res Treat; 2013 Apr; 138(3):727-39. PubMed ID: 23535840 [TBL] [Abstract][Full Text] [Related]
49. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer. Zhao H; Wilkie T; Deol Y; Sneh A; Ganju A; Basree M; Nasser MW; Ganju RK Mol Cancer; 2015 Jan; 14():11. PubMed ID: 25622979 [TBL] [Abstract][Full Text] [Related]
50. S100A7, Jab1, and p27 Granata M; Skarmoutsou E; Gangemi P; Mazzarino MC; D'Amico F J Cell Biochem; 2019 Mar; 120(3):3384-3392. PubMed ID: 30203426 [TBL] [Abstract][Full Text] [Related]
51. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway. Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323 [TBL] [Abstract][Full Text] [Related]
52. Senescence marker protein-30 regulates Akt activity and contributes to cell survival in Hep G2 cells. Matsuyama S; Kitamura T; Enomoto N; Fujita T; Ishigami A; Handa S; Maruyama N; Zheng D; Ikejima K; Takei Y; Sato N Biochem Biophys Res Commun; 2004 Aug; 321(2):386-90. PubMed ID: 15358188 [TBL] [Abstract][Full Text] [Related]
53. Integrin alpha5beta1 promotes survival of growth-arrested breast cancer cells: an in vitro paradigm for breast cancer dormancy in bone marrow. Korah R; Boots M; Wieder R Cancer Res; 2004 Jul; 64(13):4514-22. PubMed ID: 15231661 [TBL] [Abstract][Full Text] [Related]
54. Up-Regulation of Glioma-Associated Oncogene Homolog 1 Expression by Serum Starvation Promotes Cell Survival in ER-Positive Breast Cancer Cells. Xu J; Huang G; Zhang Z; Zhao J; Zhang M; Wang Y; Liu Z; Lu J Cell Physiol Biochem; 2015; 36(5):1862-76. PubMed ID: 26182949 [TBL] [Abstract][Full Text] [Related]
55. DEDD interacts with PI3KC3 to activate autophagy and attenuate epithelial-mesenchymal transition in human breast cancer. Lv Q; Wang W; Xue J; Hua F; Mu R; Lin H; Yan J; Lv X; Chen X; Hu ZW Cancer Res; 2012 Jul; 72(13):3238-50. PubMed ID: 22719072 [TBL] [Abstract][Full Text] [Related]
56. S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation. Paruchuri V; Prasad A; McHugh K; Bhat HK; Polyak K; Ganju RK PLoS One; 2008 Mar; 3(3):e1741. PubMed ID: 18320059 [TBL] [Abstract][Full Text] [Related]
57. Carboxyl-terminal modulator protein positively regulates Akt phosphorylation and acts as an oncogenic driver in breast cancer. Liu YP; Liao WC; Ger LP; Chen JC; Hsu TI; Lee YC; Chang HT; Chen YC; Jan YH; Lee KH; Zeng YH; Hsiao M; Lu PJ Cancer Res; 2013 Oct; 73(20):6194-205. PubMed ID: 23943800 [TBL] [Abstract][Full Text] [Related]
58. Knockdown of S100A7 reduces lung squamous cell carcinoma cell growth in vitro and in vivo. Liu G; Wu Q; Liu G; Song X; Zhang J Int J Clin Exp Pathol; 2014; 7(11):8279-89. PubMed ID: 25550886 [TBL] [Abstract][Full Text] [Related]
59. Fank1 interacts with Jab1 and regulates cell apoptosis via the AP-1 pathway. Wang H; Song W; Hu T; Zhang N; Miao S; Zong S; Wang L Cell Mol Life Sci; 2011 Jun; 68(12):2129-39. PubMed ID: 20978819 [TBL] [Abstract][Full Text] [Related]
60. Let-7d Inhibits Growth and Metastasis in Breast Cancer by Targeting Jab1/Cops5. Wei Y; Liu G; Wu B; Yuan Y; Pan Y Cell Physiol Biochem; 2018; 47(5):2126-2135. PubMed ID: 29975923 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]